HyperLink

Remind me about this event in:
Email Address:    

Add this Event to my Outlook Calendar

Web Sponsors

Official Journal Partner

 

Welcome to the Nucleic Acid Diagnostics & Therapeutics Summit. This inaugural summit was held in Boston, MA immediately prior to the annual RNAi World Congress, which addressed the latest research in RNAi and microRNA research.

In contrast the DxRx Summit was attended by investors, corporate management, business leaders, legal & regulatory advisors, clinical trial CROs and others who are interested in the diagnostic and therapeutic applications of DNA, RNAi, microRNA's and antisense technology.

Registered delegates were also eligible to attend a half-day interactive business tutorial on the market and business landscape for diagnostics and therapeutics based on RNAi and microRNAs hosted by Enal Razvi, PhD.

Agenda Topics

  • Reviews of Company Pipelines
  • Clinical Trial Status of Nucleic Acid-Based Therapeutics
  • Patent Status of Nucleic Acid-Based Diagnostics and Therapeutics
  • Nucleic Acid Drug Delivery
  • microRNAs as Diagnostics and Therapeutic Entities
  • Nucleic Acid Biomarkers for Personalized Medicine
  • Reimbursement and Regulatory Landscape
  • Investor Attitudes to this Sector
  • Emerging Company Showcase


Big savings on group bookings!
Click here for more information.

Confirmed Speakers Include:

Dmitry Samarsky, Vice President RXi Pharmaceuticals
Nickolay Ferrari, Director of Pharmacology, Topigen
David Evans, VP of Discovery Research, Sirnaomics
James Patton, Professor Vanderbilt University
Jörg Vollmer, Managing Director, Coley Pharmaceutical
Elena Bichenkova, Lecturer in Medicinal Chemistry, University of Manchester
Elena Feisntein, CSO Quark Pharmaceuticals
David Brown, Director of Drug Discovery, Mirna Therapeutics
Ansgar Santel, Senior Scientist, Silence Therapeutics
Johannes Fruehauf, Vice President Research, Cequent Pharma
Nobuyoshi Kosaka, National Cancer Center Research Institute
Lorna Brazell, Partner Bird & Bird
Frank Karlson, CSO, NorChip
Adam Baker
, Director of Diagnostic Product Development, Exiqon
Anne-Laure Bolcato-Bellemin, In vivo Research Manager, Polyplus-transfection
Rolf Muller, Chief Scientific Officer, Biomatrica
Amit Kumar, CEO, CombiMatrix Corp

Sponsorship Opportunities
Aaron Woodley, Exhibition Manager
a.woodley@selectbiosciences.com
+44 (0)1787 315129